Roche Holding AG
ROG
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
103,605
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,450.90 | 64.30 | -0.76% |
CAC 40 | 7,240.70 | 13.72 | 0.19% |
DAX 40 | 19,068.76 | 35.12 | 0.18% |
Dow JONES (US) | 43,910.98 | 382.15 | -0.86% |
FTSE 100 | 8,035.12 | 9.35 | 0.12% |
HKSE | 19,823.45 | 23.43 | -0.12% |
NASDAQ | 19,281.40 | 17.36 | -0.09% |
Nikkei 225 | 38,721.66 | 654.43 | -1.66% |
NZX 50 Index | 12,674.49 | 74.87 | -0.59% |
S&P 500 | 5,983.99 | 17.36 | -0.29% |
S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
SSE Composite Index | 3,439.28 | 17.31 | 0.51% |